{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:28:22Z","timestamp":1791872902566,"version":"4.3.4"},"reference-count":86,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Microbiol Rev"],"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:title>SUMMARY<\/jats:title>\n                  <jats:p>\n                    Regular review of the management of bioterrorism is essential for maintaining readiness for these sporadically occurring events. This review provides an overview of the history of biological disasters and bioterrorism. I also discuss the recent recategorization of tier 1 agents by the U.S. Department of Health and Human Services, the Laboratory Response Network (LRN), and specific training and readiness processes and programs, such as the College of American Pathologists (CAP) Laboratory Preparedness Exercise (LPX). LPX examined the management of cultivable bacterial vaccine and attenuated strains of tier 1 agents or close mimics. In the LPX program, participating laboratories showed improvement in the level of diagnosis required and referral of isolates to an appropriate reference laboratory. Agents which proved difficult to manage in sentinel laboratories included the more fastidious Gram-negative organisms, especially\n                    <jats:named-content content-type=\"genus-species\">Francisella tularensis<\/jats:named-content>\n                    and\n                    <jats:named-content content-type=\"genus-species\">Burkholderia<\/jats:named-content>\n                    spp. The recent Ebola hemorrhagic fever epidemic provided a check on LRN safety processes. Specific guidelines and recommendations for laboratory safety and risk assessment in the clinical microbiology are explored so that sentinel laboratories can better prepare for the next biological disaster.\n                  <\/jats:p>","DOI":"10.1128\/cmr.00033-15","type":"journal-article","created":{"date-parts":[[2015,12,9]],"date-time":"2015-12-09T23:34:24Z","timestamp":1449704064000},"page":"175-189","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":51,"title":["Bioterrorism and the Role of the Clinical Microbiology Laboratory"],"prefix":"10.1128","volume":"29","author":[{"given":"Elizabeth","family":"Wagar","sequence":"first","affiliation":[{"name":"University of Texas MD Anderson Cancer Center, Houston, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","first-page":"415","volume-title":"Medical aspects of chemical and biological warfare","author":"Eitzen EM","year":"1997","unstructured":"Eitzen EM, Jr , Takafuji ET . 1997. Historical overview of biological warfare, p 415\u2013423. In Sidell FR , Takafuji ET , Franz DR (ed), Medical aspects of chemical and biological warfare. Office of the Surgeon General, Borden Institute, Walter Reed Army Medical Center, Washington, DC."},{"key":"e_1_3_2_3_2","volume-title":"The rise of CB weapons","author":"Stockholm International Peace Research Institute (SIPRI)","year":"1971","unstructured":"Stockholm International Peace Research Institute (SIPRI). 1971. The problem of chemical and biological warfare, vol 1. The rise of CB weapons. Humanities Press, New York, NY."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0810.020353"},{"key":"e_1_3_2_5_2","first-page":"61084","article-title":"Possession, use and transfer of select agents and toxins, biennial review","volume":"77","author":"Department of Health and Human Services","year":"2012","unstructured":"Department of Health and Human Services. 2012. Possession, use and transfer of select agents and toxins, biennial review. Fed Regist 77:61084.","journal-title":"Fed Regist"},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","unstructured":"Elschner M Cutler S Weldmann M Butaye F (ed). 2012. BSL3 and BSL4 agents: epidemiology microbiology and practical guidelines. Wiley-Blackwell Darmstadt Federal Republic of Germany.","DOI":"10.1002\/9783527645114"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2004.12.006"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2004-830901"},{"key":"e_1_3_2_9_2","unstructured":"Los Angeles Times. 17 December 2014. 3 cases of wound botulism in O.C.: here's what it is. http:\/\/www.latimes.com\/local\/lanow\/la-me-ln-heroin-wound-botulism-california-20141217-story.html. Accessed 12 March 2015."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2003.034702"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1259657"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-010-0814-x"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.8.4330-4341.2004"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1502918"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.3390\/v4101878"},{"key":"e_1_3_2_16_2","first-page":"556","article-title":"How Ebola and Marburg viruses battle the immune system","volume":"7","author":"Mohamadzadeh M","year":"2007","unstructured":"Mohamadzadeh M , Chen L , Schmaljohn AL . 2007. How Ebola and Marburg viruses battle the immune system. Nature 7:556\u2013567.","journal-title":"Nature"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.7208\/chicago\/9780226189529.001.0001"},{"key":"e_1_3_2_18_2","first-page":"762","article-title":"Smallpox and bioterrorism","volume":"81","author":"Pennington H","year":"2003","unstructured":"Pennington H . 2003. Smallpox and bioterrorism. Bull World Health Organ 81:762\u2013767.","journal-title":"Bull World Health Organ"},{"key":"e_1_3_2_19_2","volume-title":"Scientific review of variola virus research, 1999\u20132010","author":"Kah AS","year":"2010","unstructured":"Kah AS , Smith GL (ed). 2010. Scientific review of variola virus research, 1999\u20132010. WHO Document Production Services, Geneva, Switzerland."},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1125134"},{"key":"e_1_3_2_21_2","first-page":"1","volume-title":"Animal viruses: molecular virology","author":"Martinez-Salas E","year":"2008","unstructured":"Martinez-Salas E , Sobrino F . 2008. Foot and mouth disease virus, p 1\u201338. In Animal viruses: molecular virology. Caister Academic Press, Norfolk, England."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.17.2.465-493.2004"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-1702(02)00261-7"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1409.009"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2009.07.017"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.21.2763"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.59566\/IJBS.2007.3144","article-title":"Clinical features and laboratory diagnosis of infection with the potential bioterrorism agents Burkholderia mallei and Burkholderia pseudomallei","volume":"3","author":"Gilad J","year":"2007","unstructured":"Gilad J , Schwartz D , Amsalem Y . 2007. Clinical features and laboratory diagnosis of infection with the potential bioterrorism agents Burkholderia mallei and Burkholderia pseudomallei . Int J Biomed Sci 3:144\u2013152.","journal-title":"Int J Biomed Sci"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.micro.112408.134030"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.10.1.35"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/35097083"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.micro.62.081307.162832"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0408026101"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng.705"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.56.3.182"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199909093411107"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1086\/421024"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00135-13"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-3-5"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-005-0064-0"},{"key":"e_1_3_2_40_2","volume-title":"WHO\/HTM\/TB\/2009.411","author":"World Health Organization","year":"2009","unstructured":"World Health Organization. 2009. WHO report: global tuberculosis control 2009: epidemiology, strategy, financing. WHO\/HTM\/TB\/2009.411. WHO, Geneva, Switzerland."},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1043\/2010-0098-CP.1"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1038\/417141a"},{"key":"e_1_3_2_43_2","volume-title":"Tuberculosis nucleic acid amplification testing performance evaluation program","author":"Centers for Disease Control and Prevention","year":"2004","unstructured":"Centers for Disease Control and Prevention. 2004. Tuberculosis nucleic acid amplification testing performance evaluation program. CDC, Atlanta, GA."},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.16.3.463-496.2003"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1200894"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60438-8"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.4065\/83.3.343"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1086\/496991"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid1611.100475"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083730"},{"key":"e_1_3_2_51_2","first-page":"451","volume-title":"Textbook of military medicine: warfare, weaponry, and the casualty, part I","author":"Eitzen EM","year":"1997","unstructured":"Eitzen EM . 1997. Use of biological weapons, p 451\u2013466. In Zajtchuk R , Bellamy RF (ed), Textbook of military medicine: warfare, weaponry, and the casualty, part I. Office of the Surgeon General, Department of the Army USA, Washington, DC."},{"key":"e_1_3_2_52_2","first-page":"467","volume-title":"Textbook of military medicine: warfare, weaponry, and the casualty, part I","author":"Friedlander AM","year":"1997","unstructured":"Friedlander AM . 1997. Anthrax, p 467\u2013478. In Zajtchuk R , Bellamy RF (ed), Textbook of military medicine: warfare, weaponry, and the casualty, part I. Office of the Surgeon General, Department of the Army USA, Washington, DC."},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000151070.56915.22"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1136\/amiajnl-2012-000945"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.2147\/RMHP.S56047"},{"key":"e_1_3_2_56_2","first-page":"85","article-title":"A review of plague persistence with special emphasis on fleas","volume":"46","author":"Wimsatt J","year":"2009","unstructured":"Wimsatt J , Biggins DE . 2009. A review of plague persistence with special emphasis on fleas. J Vector Borne Dis 46:85\u201399.","journal-title":"J Vector Borne Dis"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1051\/vetres:2008045"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2007.77.1103"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020002"},{"key":"e_1_3_2_60_2","first-page":"102","volume-title":"The great mortality: an intimate history of the black death, the most devastating plague of all time","author":"Kelly J","year":"2006","unstructured":"Kelly J . 2006. The great mortality: an intimate history of the black death, the most devastating plague of all time, p 102. Harper Collins, New York, NY."},{"key":"e_1_3_2_61_2","volume-title":"A journal of the plague year, 1722: being observations or memorials, of the most remarkable occurences, as well publick as private, which happened in London during the Last Great Visitation in 1665","author":"Defoe D","year":"2013","unstructured":"Defoe D . 2013. A journal of the plague year, 1722: being observations or memorials, of the most remarkable occurences, as well publick as private, which happened in London during the Last Great Visitation in 1665. Forgotten Books, London, United Kingdom. (Original work published 1722.)"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1086\/313824"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00005-11"},{"key":"e_1_3_2_64_2","volume-title":"Biosafety in microbiological and biomedical laboratories","author":"US Department of Health and Human Services","year":"2009","unstructured":"US Department of Health and Human Services. 2009. Biosafety in microbiological and biomedical laboratories, 5th ed. HHS publication no. (CDC) 21-1112. HHS, Washington, DC.","edition":"5"},{"key":"e_1_3_2_65_2","unstructured":"American Society for Microbiology. 2006. Sentinel laboratory guidelines for suspected agents of bioterrorism: clinical laboratory bioterrorism readiness plan. http:\/\/www.asm.org\/ccLibraryFiles\/FILENAME\/000000002178\/BTtemplate3-02-06.pdf . ASM Washington DC. Accessed 23 February 2015."},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.publhealth.28.021406.144054"},{"key":"e_1_3_2_67_2","first-page":"83","article-title":"Winds of change\u2014training, checklists, pricing","volume":"2002","author":"Carlson D","year":"2002","unstructured":"Carlson D . February 2002. Winds of change\u2014training, checklists, pricing. CAP Today 2002:83.","journal-title":"CAP Today"},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1177\/153567600601100403"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.94.7.1093"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1086\/503260"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1086\/600885"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.femsle.2004.12.020"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.M700339-MCP200"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mimet.2008.06.016"},{"key":"e_1_3_2_75_2","doi-asserted-by":"publisher","DOI":"10.1128\/AEM.65.10.4313-4319.1999"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00267-13"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.05996-11"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1404505"},{"key":"e_1_3_2_79_2","unstructured":"World Health Organization. 29 August 2014. WHO: Ebola response roadmap: situation report 1. WHO Geneva Switzerland. http:\/\/www.who.int\/csr\/disease\/ebola\/situation-reports\/archive\/en . Accessed 2 March 2015."},{"key":"e_1_3_2_80_2","unstructured":"Centers for Disease Control and Prevention. 2014. Ebola outbreak in West Africa. CDC Atlanta GA. http:\/\/www.cdc.gov\/vhf\/ebola\/outbreaks\/2014-west-africa\/index.html . Accessed 2 March 2015."},{"key":"e_1_3_2_81_2","unstructured":"Occupational Safety and Health Administration. 2011. Bloodborne pathogens standard 29 CFR 1910.1030. OSHA Washington DC. https:\/\/www.osha.gov\/pls\/oshaweb\/owadisp.show_document?p_table=STANDARDS&p_id=10051 . Accessed 2 March 2015."},{"key":"e_1_3_2_82_2","volume-title":"CLSI document M29-A4","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2014","unstructured":"Clinical and Laboratory Standards Institute (CLSI). 2014. Protection of laboratory workers from occupationally acquired infections; approved guideline, 4th ed. CLSI document M29-A4. Clinical and Laboratory Standards Institute, Wayne, PA.","edition":"4"},{"key":"e_1_3_2_83_2","doi-asserted-by":"crossref","unstructured":"Siegel JD Rhinehart E Jackson M Chiarello L Healthcare Infection Control Practices Advisory Committee. 2007. Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings. CDC Atlanta GA. http:\/\/www.cdc.gov\/ncidod\/dhqp\/pdf\/isolation2007.pdf . Accessed 24 February 2015.","DOI":"10.1016\/j.ajic.2007.10.007"},{"key":"e_1_3_2_84_2","first-page":"1","article-title":"Guidelines for safe work practices in human and animal medical diagnostic laboratories. Recommendations of a CDC-convened, Biosafety Blue Ribbon Panel","volume":"61","author":"Miller JM","year":"2012","unstructured":"Miller JM , Astles R , Baszler T , Chapin K , Carey R , Garcia L , Gray L , Larone D , Pentella M , Pollock A , Shapiro DS , Weirich E , Wiedbrauk D , Biosafety Blue Ribbon Panel, Centers for Disease Control and Prevention (CDC). 2012. Guidelines for safe work practices in human and animal medical diagnostic laboratories. Recommendations of a CDC-convened, Biosafety Blue Ribbon Panel. MMWR Surveill Summ 61(Suppl):1\u2013102.","journal-title":"MMWR Surveill Summ"},{"key":"e_1_3_2_85_2","first-page":"130","volume-title":"Laboratory management for pathologists","author":"Wagar EA","year":"2011","unstructured":"Wagar EA , Horowitz RE , Siegal G . 2011. Quality management in laboratory medicine, p 130\u2013132. In Laboratory management for pathologists. CAP Press, Northfield, IL."},{"key":"e_1_3_2_86_2","volume-title":"The basics of FMEA","author":"Mikulak RJ","year":"2008","unstructured":"Mikulak RJ , McDermott R , Beauregard M (ed). 2008. The basics of FMEA, 2nd ed. Productivity Press, New York, NY.","edition":"2"},{"key":"e_1_3_2_87_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.14.2.364-381.2001"}],"container-title":["Clinical Microbiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CMR.00033-15","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CMR.00033-15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T14:46:23Z","timestamp":1748702783000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CMR.00033-15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":86,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.1128\/CMR.00033-15"],"URL":"https:\/\/doi.org\/10.1128\/cmr.00033-15","relation":{},"ISSN":["0893-8512","1098-6618"],"issn-type":[{"value":"0893-8512","type":"print"},{"value":"1098-6618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"2015-12-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}